Let's also remember, none of the big pharma players are in the canaloplasty MIGS space.
In 2016, Allergen bought stent company/procedure Aquesys for $300m. Alcon bought Ivantus (mad ethe Hydrus stent) for $475m.
These purchases gives some idea of the imbedded value of these procedures!
Nova Eye Medical (EYE) Discussion, page-6
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
-0.005(2.63%) |
Mkt cap ! $42.37M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $69.95K | 368.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 151180 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 109576 | 2 |
View Market Depth
| Last trade - 12.37pm 09/09/2024 (20 minute delay) ? |
| EYE (ASX) Chart |